Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 4Sarcoma 2Lymphoid 2Other hematologic neoplasm 1Endocrine 1

Conditions

Lymphoma 26Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Lymphoma, Large B-Cell, Diffuse 21Lymphoma, Non-Hodgkin 19Lymphoma, Mantle-Cell 17Lymphoma, Follicular 16Hodgkin Disease 15Lymphoma, T-Cell, Cutaneous 13Leukemia, Lymphocytic, Chronic, B-Cell 12Mycosis Fungoides 11Lymphoma, B-Cell, Marginal Zone 11Leukemia, Myeloid, Acute 11Burkitt Lymphoma 11Sezary Syndrome 9Lymphoma, Large-Cell, Anaplastic 8Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, T-Cell 7Lymphoma, Large-Cell, Immunoblastic 7Immunoblastic Lymphadenopathy 7Blast Crisis 7Myeloproliferative Disorders 6Lymphoma, Extranodal NK-T-Cell 6Lymphoma, B-Cell 6Leukemia 6Waldenstrom Macroglobulinemia 5Recurrence 5Multiple Myeloma 5Leukemia, Myelomonocytic, Chronic 5Leukemia, Myeloid, Accelerated Phase 5Congenital Abnormalities 5

Interventions

X-Rays 6Phantoms, Imaging 6Magnetic Resonance Spectroscopy 6Specimen Handling 5Nuclear Medicine Department, Hospital 5Filgrastim 4Biopsy 4ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2Vorinostat 2Topotecan 2Psychiatric Rehabilitation 2Peripheral Blood Stem Cell Transplantation 2LY3023414 2Etoposide 2Cyproheptadine 2Carboplatin 2Bortezomib 2trioctyl phosphine oxide 1trametinib 1sonidegib 1romidepsin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Medulloblastoma × Vorinostat × Lymphoid × Clear all
NCT00217412 2014-06-17

Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia

National Cancer Institute (NCI)

Phase 1 Completed
60 enrolled
CNSLymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Medulloblastoma, Neuroblastoma, Recurrence, Lymphoma, Large B-Cell, Diffuse, Rhabdoid Tumor, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Dendritic Cell Sarcoma, Interdigitating

NCT00994500 2013-07-02

Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma

National Cancer Institute (NCI)

Phase 1 Completed
20 enrolled
CNSLymphoidSarcoma

Familial ependymoma, Astrocytoma, Burkitt Lymphoma, Medulloblastoma, Meningioma, Oligodendroglioma, Recurrence, Lymphoma, Large B-Cell, Diffuse, Choroid Plexus Neoplasms, Lymphoma, Large-Cell, Anaplastic, Optic Nerve Glioma, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡